Since late 2021 NASDAQ:MEDP is being forming a head & shoulders base with pivot buy above $230. This is the beahvior of a potential leader. It shows when comparing it against the AMEX:IWO as is still in a downtrend. The play for me would be to buy 1/2 or 1/3 of a position just above yesterday's high with a STOP-LOSS below $196. And then add at the $230...
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. They do clinical trials for new drugs, including a recent trial for a neutralizing antibody for SARS-CoV-2 for the treatment and prevention of...
MEDP seems running within an upward channel formation. Right now it's getting back from its upper Chanel line. It also has some 100% selles from insider. We think it has good downside potential. To trade one could consider June $55 or $60 Puts ------------------- *Trade Idea* Date First Found- February 11, 2019 Pattern/Why- Upward Channel formation Entry...